MEDI3250
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MEDI3250, covering 2015-09-28 to 2015-12-03. Get the full timeline:
Most recent: Clinical Trial Update: A Phase3 Study to Evaluate the Efficacy and Safety of MEDI3250 in Healthy Japanese Children Age 7 Years Through 18 Years [Phase 3]